+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 65Years +
All Genders
Healthy Volunteers
ID06448403

Multimodal Brain Assessment to Understand Alzheimers Disease and Cognitive Impairment

Led by Norwegian University of Science and Technology · Updated on 2026-08-13

60

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying brain changes in patients with mild cognitive impairment MCI and Alzheimers Disease AD to better understand how these conditions develop and differ from healthy brains. The study aims to identify early signs that predict the development of Alzheimers and to compare brain changes among healthy individuals, those with MCI, and those with AD. Participants will undergo a variety of assessments including magnetic resonance imaging MRI to examine brain structure and function, 64-channel electroencephalography EEG to measure electrical brain activity, blood and fecal sample collection to analyze biomarkers and bacterial composition, and cognitive tests to evaluate specific areas of cognitive function. A randomized subset of participants will also have polysomnography to study sleep patterns. Throughout the study, participants will complete cognitive testing and undergo imaging and sample collection at scheduled times. Researchers will monitor changes over five years, focusing on the progression from MCI to AD and differences within AD subtypes. Safety and eligibility for imaging devices will be ensured, and participants brain health and cognitive status will be closely observed during this period.

CONDITIONS

Brief Title

Multimodal Assesment of Alzheimer Patients

Research Team

A

Axel Sandvig, Prof., MD, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here